Cash Flow Statement

Altimmune (ALT) Return on Capital Employed Growth (3y) (2015 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE Growth (3y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn -494.00
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -649.00
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 4,853.00
10 Altimmune 379.61 Mn 379.61 Mn - 1,674.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 1,674.00
Dec 31, 2025 373.00
Sep 30, 2025 -326.00
Jun 30, 2025 -728.00
Mar 31, 2025 -1,832.00
Dec 31, 2024 -3,127.00
Sep 30, 2024 -3,695.00
Jun 30, 2024 -3,887.00
Mar 31, 2024 -2,819.00
Dec 31, 2023 -3,023.00
Sep 30, 2023 -2,242.00
Jun 30, 2023 581.00
Mar 31, 2023 554.00
Dec 31, 2022 -224.00
Sep 30, 2022 3,455.00
Jun 30, 2022 1,188.00
Mar 31, 2022 1,689.00
Dec 31, 2021 4,069.00
Sep 30, 2021 2,685.00
Jun 30, 2021 8,385.00
Mar 31, 2021 6,878.00
Dec 31, 2020 5,612.00
Sep 30, 2020 2,743.00
Jun 30, 2020 -1,876.00
Mar 31, 2020 511.00
Dec 31, 2019 -2,618.00
Sep 30, 2019 -6,779.00
Jun 30, 2019 -3,475.00
Mar 31, 2019 -3,454.00
Dec 31, 2018 -6,823.00
Sep 30, 2018 -3,731.00
Jun 30, 2018 -7,534.00
Mar 31, 2018 -5,969.00
Jun 30, 2017 6,145.00
Mar 31, 2017 3,877.00
Dec 31, 2016 7,404.00
Sep 30, 2016 3,121.00
Jun 30, 2016 1,003.00
Mar 31, 2016 465.00
Dec 31, 2015 2,150.00
Sep 30, 2015 934.00
Jun 30, 2015 256.00
Mar 31, 2015 1,298.00